NEW YORK (GenomeWeb News) – Accelerate Diagnostics has filed a shelf registration to publicly offer from time to time up to $150 million of securities.

In a Form S-3 filed with the US Securities and Exchange Commission on Wednesday, the company said that it may offer common stock, preferred stock, debt securities, warrants, and/or units in combination. Net proceeds from any offering will go toward general corporate purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.